Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesBarclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
IonQ just crossed a historic revenue milestone, signaling a turning point for pure-play quantum investing. This artic...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
Gemini Space Station stock has faced a sharp weekly drop as analysts trim targets after a mixed earnings update. This...
Appleās shares tumbled after WWDC-style AI updates raised questions about iPhone upgrades and monetization. This guid...
In 2026, Palantir and Sandisk both delivered blowout earnings, but their stock moves told different stories. This art...
Nu Holdings faced a sharp February drop as U.S. expansion uncertainty and broader macro headwinds collided with stron...
Tesla stock slides as delivery fears collide with SpaceX IPO chatter and a Cybercab roadmap, leaving investors weighi...
Virgin Galactic leads a broad rally in space stocks after a liquidity-boosting debt-for-equity swap. AST SpaceMobile,...
Tesla trades around $370 as investors await Q2 2026 results, balancing a mature auto business with a growing software...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...